OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
3
Results
Show all
Save search
Copy query
Show results for
Unknown
(2)
Metabolomics
(1)
Repository
MetaboLights
(1)
Technology Type
Mass spectrometry assay
(1)
Instrument Platform
Liquid Chromatography MS - negative - hilic
(1)
Liquid Chromatography MS - positive - hilic
(1)
Publication Date
2025
(1)
CHEBI ID
CHEBI:232842
(1)
CHEBI:30916
(1)
CHEBI:173869
(1)
CHEBI:167870
(1)
CHEBI:89312
(1)
CHEBI:88785
(1)
CHEBI:89730
(1)
CHEBI:168922
(1)
CHEBI:84842
(1)
CHEBI:145961
(1)
CHEBI:86073
(1)
CHEBI:17295
(1)
CHEBI:7676
(1)
CHEBI:9300
(1)
CHEBI:17895
(1)
CHEBI:15741
(1)
CHEBI:30769
(1)
CHEBI:44747
(1)
CHEBI:6650
(1)
CHEBI:17445
(1)
CHEBI:32805
(1)
Metabolite Name
Butenylcarnitine
(1)
Decenedioic acid
(1)
Dodecenedioic acid
(1)
Cis-Aconitate
(1)
3-Hydroxyphenylacetate
(1)
3-Hydroxyphenyllactate
(1)
3-Hydroxyphenylpyruvate
(1)
Homogentisate
(1)
(E)-10-Oxo-8-decenoic acid
(1)
2-Hydroxydecanedioic acid
(1)
2-Oxoglutarate
(1)
3-Hydroxydodecanedioic acid
(1)
Malate
(1)
Citrate
(1)
Succinic acid
(1)
Suberic acid
(1)
Release Date
2018
(1)
2016
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Nitisinone’s mosquitocidal properties hold promise for malaria control
Nitisinone’s mosquitocidal properties hold promise for malaria control
2025-06-16
|
MTBLS11617
|
MetaboLights
Cite
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.
Not available
S-EPMC6067798
|
biostudies-literature
Cite
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.
Not available
S-EPMC4872017
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
